Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Ellie, Dow"'
Autor:
Doug Kidd, Samira Bell, Huan Wang, Jayne Digby, Paul Brennan, John Dillon, Ellie Dow, Andrew Taylor, Ify Mordi, Chim Lang, Colin Palmer, Claire Andrews, Albert Farre, Peter Donnan, Ewan Pearson, Rachael Barrett, Rodolfo Hernández, Sam Philip, Rory McCrimmon, Mandy Ryan, Tim J Croudace, Alex Doney, Susan Morrow, Damien Leith, Karen Wilson, Christopher Schofield, Russell Petty, Michael Abbott, Lewis Moonie, Anna Barnett, David Baty, YeunYi Lin, Stephanie McKenzie, Cameron Munro, Deborah Wake, Mya Win, Brian Allardice, Emma Riches, Erin Middleton, Evelyn Anyebe, Jacob Francis, Joanne McLean, Gerry Tosh, Louise Bremner, Louise Donnelly, Nicola Andrew, Simon Boyd, Tegwen Sundar Srinivasan, Valerie Godfrey O'Rourke, Victoria Sullivan Vera Ferutova, William Urquart
Publikováno v:
BMJ Open, Vol 14, Iss 11 (2024)
Introduction and aim Diabetes is a global health emergency with increasing prevalence and diabetes-associated morbidity and mortality. One of the challenges in optimising diabetes care is translating research advances in this heterogeneous disease in
Externí odkaz:
https://doaj.org/article/f788265366f54beeb4ae1c608b832e9d
Autor:
Madeline Pearson, Jennifer Nobes, Iain Macpherson, Lucy Gold, Michael Miller, Ellie Dow, John F. Dillon
Publikováno v:
JHEP Reports, Vol 6, Iss 6, Pp 101062- (2024)
Background & Aims: In community pathways for detection of liver disease the most common reason for referral is fibrosis assessment. We investigated the impact of adding the Enhanced Liver Fibrosis (ELF) score as a second-line test (subsequent to an i
Externí odkaz:
https://doaj.org/article/5faf0e4bb0824886bbfb5915c7332f89
Publikováno v:
Diagnostics, Vol 14, Iss 9, p 960 (2024)
The intelligent Liver Function Testing (iLFT) pathway is a novel, algorithm-based system which provides automated laboratory investigations and clinical feedback on abnormal liver function test (LFT) results from primary care. iLFT was introduced to
Externí odkaz:
https://doaj.org/article/23d93516a5d141a2ba508b64dcc5d573
Autor:
David Craig, Michael J. Murphy, Fiona Brandie, Mildred Ebare, William A. Bartlett, Michelle Harrison, Ellie Dow
Publikováno v:
Annals of Clinical Biochemistry
Background Assessing the pre- and post-test probability of disease in the context of routine health care is challenging. We wished to study how test performance parameters relating to clinical utility vary by clinical indication in a ‘real-world’
Autor:
Elizabeth Furrie, Jennifer Nobes, Michael D. Miller, Ellie Dow, Iain Macpherson, John F. Dillon, Callum Livingstone
Publikováno v:
Posters.
Autor:
Jennifer Nobes, Elizabeth Furrie, Iain Macpherson, Callum Livingstone, Ellie Dow, John F. Dillon, Michael D. Miller
Publikováno v:
Posters.
Autor:
Madeline Pearson, Iain Macpherson, Jennifer Nobes, Elizabeth Furrie, Michael Miller, Ellie Dow, John Dillon
Publikováno v:
Journal of Hepatology. 77:S495-S496
Autor:
Michael H Miller, P. G. McIntyre, Kathleen A Boyd, Mohsen Rezaeihemami, Adrian Hapca, Bill Bartlett, Ellie Dow, Emma Robinson, Christopher J Weatherburn, John F. Dillon, Peter T. Donnan
Publikováno v:
Journal of Hepatology. 71:699-706
Background & Aims Liver function tests (LFTs) are frequently requested blood tests which may indicate liver disease. LFTs are commonly abnormal, the causes of which can be complex and are frequently under investigated. This can lead to missed opportu
Autor:
Cassandra Baiano, Jennifer Nobes, Iain Macpherson, Callum Livingstone, Madeleine Caven, Paul Brennan, Ellie Dow, John Dillon
Publikováno v:
Journal of Hepatology. 77:S415
Autor:
Jennifer Nobes, John F. Dillon, Michael H Miller, Elizabeth Furrie, Ellie Dow, Iain Macpherson
Publikováno v:
Oral.
Introduction Liver Function Tests (LFTs) are abnormal in 20% of cases in primary care. In addition, mortality from chronic liver disease continues to rise. Intelligent liver function testing (iLFT) was designed to improve diagnosis of liver disease,